Extensions

U.S. Patent 11,100,163: Term, Continuations, and Family Data

Report Date: May 9, 2026

This report details the status and history of U.S. Patent 11,100,163 ('163 patent), including its projected expiration date, related applications, and patent family.

Patent Term and Expiration

• Filing Date: The application for the '163 patent (US 16/205,073) was filed on November 29, 2018.
• Priority Date: The '163 patent claims priority to an earlier application filed on July 29, 2008. The term of a U.S. patent is generally 20 years from the filing date of the earliest U.S. or international application to which priority is claimed (excluding provisional applications).
• Patent Term Adjustment (PTA): There is no indication of any Patent Term Adjustment (PTA) for the '163 patent. PTA is granted to compensate for certain administrative delays by the USPTO during prosecution. The absence of PTA suggests the application was processed within the standard timeframes.
• Patent Term Extension (PTE): There is no record of a Patent Term Extension (PTE) for this patent. PTE is typically granted for delays caused by pre-market regulatory review, such as by the Food and Drug Administration (FDA), and is not applicable to this technology area.
• Projected Expiration Date: Based on the 20-year term calculated from the earliest priority date of July 29, 2008, the projected expiration date for U.S. Patent 11,100,163 is July 29, 2028. This is subject to the timely payment of all required maintenance fees.

Continuation and Divisional Applications

The '163 patent is a continuation of a series of prior applications. A continuation application is a new application for an invention disclosed in an earlier "parent" application, which allows the applicant to pursue different claims.

• Direct Parent Application: The '163 patent is a continuation of U.S. Patent Application No. 15/727,045, filed on October 6, 2017 (now abandoned).
• Earlier Parent Application: Application 15/727,045 is a continuation of U.S. Patent Application No. 13/900,495, filed on May 22, 2013, which issued as U.S. Patent No. 9,792,361.
• Original Application: Application 13/900,495 is a continuation of the original application, U.S. Patent Application No. 12/181,956, filed on July 29, 2008, which issued as U.S. Patent No. 8,775,454.

There is no evidence of any divisional applications filed from this patent family. A divisional application is typically filed when the USPTO determines that an application claims more than one independent invention.

Patent Family Members

The '163 patent is part of a larger family of related patents and applications that share a common priority date. The known U.S. members of this patent family, assigned to Mimzi LLC, include:

• U.S. Patent No. 8,775,454: Issued July 8, 2014.
• U.S. Patent No. 9,128,981: Issued September 8, 2015. (This patent is a continuation of a separate chain of applications also stemming from the original 2008 application).
• U.S. Patent No. 9,792,361: Issued October 17, 2017.
• U.S. Patent No. 11,086,929: Issued August 10, 2021.
• U.S. Patent No. 11,308,156: Issued April 19, 2022.
• U.S. Patent No. 11,782,975: Issued October 10, 2023.

All patents in this family share the same priority date of July 29, 2008, and therefore have the same projected expiration date of July 29, 2028, contingent upon payment of maintenance fees. The existence of this extensive patent family demonstrates a strategic approach by the assignee to build a broad portfolio of claims around the core invention.